Որոնման արդյունքները - Rob E. Aarnoutse
- Ցուցադրվում են 1 - 20 արդյունքները 52
- Գնացեք Հաջորդ էջ
-
1
-
2
-
3
-
4
-
5
-
6
Cost Evaluation of Dried Blood Spot Home Sampling as Compared to Conventional Sampling for Therapeutic Drug Monitoring in Children Lisa C. Martial, Rob E. Aarnoutse, Michiel F. Schreuder, Stefanie Henriet, Roger J. M. Brüggemann, Manuela Joore
Հրապարակվել է 2016Artigo -
7
-
8
-
9
-
10
Isoniazid, Rifampin, and Pyrazinamide Plasma Concentrations in Relation to Treatment Response in Indonesian Pulmonary Tuberculosis Patients Erlina Burhan, Carolien Ruesen, Rovina Ruslami, Arum Ginanjar, Hadiarto Mangunnegoro, Purwantyastuti Ascobat, Rogier Donders, Reinout van Crevel, Rob E. Aarnoutse
Հրապարակվել է 2013Artigo -
11
-
12
A Population Pharmacokinetic Model Incorporating Saturable Pharmacokinetics and Autoinduction for High Rifampicin Doses Robin J. Svensson, Rob E. Aarnoutse, Andreas H. Diacon, Rodney Dawson, Stephen H. Gillespie, Martin J. Boeree, Ulrika S. H. Simonsson
Հրապարակվել է 2017Artigo -
13
-
14
Pharmacogenetics and Pharmacokinetics of Moxifloxacin in MDR-TB Patients in Indonesia: Analysis for ABCB1 and SLCO1B1 Nurul Annisa, Nadiya Nurul Afifah, Prayudi Santoso, Vycke Yunivita, Lindsey H. M. te Brake, Rob E. Aarnoutse, Melisa Intan Barliana, Rovina Ruslami
Հրապարակվել է 2025Artigo -
15
Pharmacokinetics of Moxifloxacin in Cerebrospinal Fluid and Plasma in Patients with Tuberculous Meningitis Jan‐Willem C. Alffenaar, Richard van Altena, H. J. Bökkerink, Gert Jan Luijckx, Dick van Soolingen, Rob E. Aarnoutse, Tjip S. van der Werf
Հրապարակվել է 2009Artigo -
16
Model-Based Meta-analysis of Rifampicin Exposure and Mortality in Indonesian Tuberculous Meningitis Trials Elin M. Svensson, Sofiati Dian, Lindsey te Brake, Ahmad Rizal Ganiem, Vycke Yunivita, Arjan van Laarhoven, Reinout van Crevel, Rovina Ruslami, Rob E. Aarnoutse
Հրապարակվել է 2019Revisão -
17
Engaging community pharmacy in tuberculosis case detection (ENHANCE): a study protocol for an implementation study in Indonesia Ivan Surya Pradipta, Carla Florencia, Cut Ainul Mardhiyyah, Firda Shafira Nurfadila, Kevin Aprilio, Rizky Abdulah, Bony Wiem Lestari, Rovina Ruslami, Trisasi Lestari, Rob E. Aarnoutse
Հրապարակվել է 2025Artigo -
18
Greater Early Bactericidal Activity at Higher Rifampicin Doses Revealed by Modeling and Clinical Trial Simulations Robin J. Svensson, Elin M. Svensson, Rob E. Aarnoutse, Andreas H. Diacon, Rodney Dawson, Stephen H. Gillespie, Vineshree Mischka Moodley, Martin J. Boeree, Ulrika S. H. Simonsson
Հրապարակվել է 2018Artigo -
19
Inhibitory Potential of Antifungal Drugs on ATP-Binding Cassette Transporters P-Glycoprotein, MRP1 to MRP5, BCRP, and BSEP Vincent J. Lempers, Jeroen J. M. W. van den Heuvel, Frans G. M. Rüssel, Rob E. Aarnoutse, David M. Burger, Roger J. M. Brüggemann, Jan J. Koenderink
Հրապարակվել է 2016Artigo -
20
Evaluation of moxifloxacin for the treatment of tuberculosis: 3 years of experience Arianna D. Pranger, Richard van Altena, Rob E. Aarnoutse, Dick van Soolingen, D. R. A. Uges, Jos G.W. Kosterink, Tjip S. van der Werf, Jan‐Willem C. Alffenaar
Հրապարակվել է 2011Artigo
Որոնման գործիքներ:
Առնչվող խորագիր
Medicine
Pathology
Tuberculosis
Pharmacology
Internal medicine
Pharmacokinetics
Biology
Rifampicin
Microbiology
Antibiotics
Isoniazid
Adverse effect
Intensive care medicine
Drug
Ethambutol
Mycobacterium tuberculosis
Pyrazinamide
Environmental health
Population
Surgery
Dosing
Gastroenterology
Immunology
Moxifloxacin
Antibacterial agent
Confidence interval
Gene
Pharmacodynamics
Sputum
Therapeutic drug monitoring